Keymed Biosciences shares rise on $320 mln windfall from Gilead-Ouro deal

Corroborated by 1 source from 1 publisher

globalgeneral10h ago

TL;DR

According to investing.com, keymed Biosciences shares rise on $320 mln windfall from Gilead-Ouro deal.

Investing.com News

https://www.investing.com/news/stock-market-news/keymed-biosciences-shares-rise-on-320-mln-windfall-from-gileadouro-deal-4576582